In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs(®) 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2

The occurrence of immune-evasive SARS-CoV-2 strains emphasizes the importance to search for broad-acting antiviral compounds. Our previous in vitro study showed that Pelargonium sidoides DC. root extract EPs(®) 7630 has combined antiviral and immunomodulatory properties in SARS-CoV-2-infected human...

Descripción completa

Detalles Bibliográficos
Autores principales: Emanuel, Jackson, Papies, Jan, Galander, Celine, Adler, Julia M., Heinemann, Nicolas, Eschke, Kathrin, Merz, Sophie, Pischon, Hannah, Rose, Ruben, Krumbholz, Andi, Kulić, Žarko, Lehner, Martin D., Trimpert, Jakob, Müller, Marcel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410074/
https://www.ncbi.nlm.nih.gov/pubmed/37564181
http://dx.doi.org/10.3389/fphar.2023.1214351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410074/
https://www.ncbi.nlm.nih.gov/pubmed/37564181
http://dx.doi.org/10.3389/fphar.2023.1214351

Ejemplares similares